Blog

NPR’s Marketplace features PAL Director discussing GSK’s alli

NPR’s Marketplace morning featured two stories today on the launch of GSK’s over-the-counter weight loss drug alli. One of these stories featured Prescription Access Litigation director Alex Sugerman-Brozan discussing alli and why it should not be available over-the-counter. A streaming version of the story can be found here.

Related posts

  • No Related Post
Donate to PAL (via PayPal)Take Action: Get Involved

2 Responses to “NPR’s Marketplace features PAL Director discussing GSK’s alli”

  1. Sue Says:

    Nice post! You have said it very well. Keep going.

  2. truthman30 Says:

    http://alliconnect.wordpress.com/

    Its seems alli has a lot of side effects…

    possibly colon cancer and a lot of number twos…

Leave a Reply